A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects

NCT03197779 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

691

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombosis

Interventions

DRUG: BMS-962212
DRUG: Aspirin
OTHER: Placebo

Sponsor

Bristol-Myers Squibb